The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 67

More JCP Articles

JCP
Review Article

July 28, 2020

Pharmacokinetics of antipsychotics are generally slower centrally than peripherally. This review examined the possible dissociation between central D2 receptor occupancy with antipsychotics and their peripheral blood concentrations.
, , , et al
JCP
Original Research

July 28, 2020

The Affordable Care Act of 2010, implemented in 2014, expanded access to outpatient mental health services, potentially reducing reliance on emergency departments (EDs). This study examined trends in mental…
, ,
JCP
Letter to the Editor

July 28, 2020

Read a letter discussing psychiatric side effects that may arise with the use of Chloroquine.
, , , et al
JCP
Clinical and Practical Psychopharmacology

July 21, 2020

Concerns have been expressed that stimulant drugs may increase seizure risk, but some studies also suggest otherwise. This column considers the findings in the context of the study methodologies…
JCP
Original Research

July 21, 2020

What is the efficacy of antidepressants and other agents for treating cognitive impairment in adults with major depressive disorder? Review available research in this CME journal activity.
, ,
JCP
Educational Activity

July 21, 2020

Read an article on how to diagnose narcolepsy and which patients need evaluation for excessive daytime sleepiness and central hypersomnias.
JCP
Original Research

July 14, 2020

Read study discussing the treatment of MDD through modulation of dysregulated glutamate neurotransmission.
, , , et al
JCP
Original Research

July 7, 2020

How many older adults receive electroconvulsive therapy (ECT) for treatment-resistant depression? Among those who receive ECT, how many finish the course? What factors might predict patients’ continuation of ECT?…
, , , et al
JCP
Original Research

July 7, 2020

Read the full article comparing outcomes of MDD treated with transcranial magnetic stimulation (TMS) in veterans with and without comorbid PTSD.
, , , et al
JCP
SPRAVATO® (esketamine) CIII Nasal Spray: The First and Only N-Methyl D-Aspartate (NMDA) Receptor Antagonist Approved in Conjunction With an Oral Antidepressant for the Treatment of Adults With Treatment-Resistant Depression
Information from Industry

June 30, 2020

JCP
Brief Report

June 30, 2020

This case series investigates the potential for nitrous oxide to rapidly reduce symptoms of posttraumatic stress disorder. Did it help the 3 Veteran outpatients who received it? Read this…
, , , et al
JCP
Original Research

June 30, 2020

Aside from intramuscular injection, few rapidly acting pharmacotherapeutic treatments are available for acute agitation. This study examined the safety and tolerability of INP105, a drug-device combination product that allows…
, , , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe